Description
A histamine H2 receptor antagonist (Ki = 0.6 μM); also acts as an inverse agonist, inhibiting basal cAMP production in CHO cells expressing recombinant H2 receptors (IC50 = 1.2 μM); inhibits histamine-induced acid secretion from isolated bullfrog gastric mucosa (IC50 = 16 μM); inhibits histamine-induced gastric acid secretion in gastric fistulae and Heidenhain pouches in dogs (ED50 = 1.88 μmol/kg, p.o.); reduces tumor growth and neovascularization in a CMT93 colon cancer mouse syngeneic model at 20 mg/kg per day
Formal name: N-cyano-N”-methyl-N’-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]-guanidine
Synonyms: NSC 335308|SKF 92334
Molecular weight: 252.3
CAS: 51481-61-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Receptor Pharmacology|Inverse Agonists||Research Area|Cancer|Angiogenesis||Research Area|Immunology & Inflammation|Gastric Disease